Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across Asia

▴ Quadria Capital Invests $102 Million in NephroPlus
The demand for dialysis services in NephroPlus' targeted markets is projected to surge by more than 11% annually over the next five years.

In a significant move to bolster healthcare services, Singapore-based private equity firm Quadria Capital has announced a substantial investment of $102 million (approximately Rs 850 crore) in NephroPlus, known as Asia’s largest dialysis network. This investment marks a pivotal step in expanding access to high-quality dialysis services across India and other growing markets in Asia.

Quadria Capital will acquire a notable minority stake in NephroPlus through a combination of primary investment and the purchase of shares from existing shareholders, as outlined in a recent company statement. This infusion of capital will empower NephroPlus to meet the escalating demand for reliable and affordable dialysis services in the region.

Established in 2010, NephroPlus has solidified its presence in substantial and high-growth markets across Asia, with a dominant position in India and a rapidly expanding footprint in the Philippines and other Asian countries. The company is poised to leverage this investment to further consolidate its leadership and enhance patient care delivery.

The demand for dialysis services in NephroPlus' targeted markets is projected to surge by more than 11% annually over the next five years, highlighting the critical need for expanded healthcare infrastructure and expertise in renal care.

Vikram Vuppala, the founder and CEO of NephroPlus, expressed enthusiasm about the investment, stating, “Our business has undergone remarkable evolution in recent years, and today we take pride in being one of the fastest-growing and most trusted providers of high-quality dialysis to approximately 30,000 patients. We are committed to expanding our footprint in India, our core market, while exploring new avenues to extend our clinical excellence and expertise to more patients globally.”

This strategic partnership between Quadria Capital and NephroPlus signifies a transformative development in the healthcare landscape, promising enhanced access to critical dialysis services and driving innovation in renal care across Asia.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026